HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

被引:0
|
作者
Qi Sun
Qi Li
Fuping Gao
Hongyan Wu
Yao Fu
Jun Yang
Xiangshan Fan
Xiaobin Cui
Xiaohong Pu
机构
[1] Nanjing Drum Tower Hospital,Department of Pathology
[2] The Affiliated Hospital of Nanjing University Medical School,Center for Digestive Medicine
[3] Nanjing Drum Tower Hospital,Department of Pathology
[4] The Affiliated Hospital of Nanjing University Medical School,undefined
[5] Gaochun People’s Hospital,undefined
关键词
Colorectal carcinomas; HER2; Fluorescence in situ hybridization; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:579 / 592
页数:13
相关论文
共 50 条
  • [1] HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria
    Sun, Qi
    Li, Qi
    Gao, Fuping
    Wu, Hongyan
    Fu, Yao
    Yang, Jun
    Fan, Xiangshan
    Cui, Xiaobin
    Pu, Xiaohong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 579 - 592
  • [2] Comparison of fluorescence in situ hybridization (FISH) with immunohistochemistry (IHC) for detection of HER2/neu amplification/overexpression in breast cancer.
    Sun, G
    Morales, JS
    Wilz, S
    McKee, C
    Amberson, J
    Gersen, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 107 - 107
  • [3] Her2 amplification - Correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Wixom, CR
    Albers, EA
    Weidner, N
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) : 248 - 251
  • [4] Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
    Yano, T
    Doi, T
    Ohtsu, A
    Boku, N
    Hashizume, K
    Nakanishi, M
    Ochiai, A
    ONCOLOGY REPORTS, 2006, 15 (01) : 65 - 71
  • [5] Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
    Ming Chen
    Yan Li
    Zhou Ming
    Ai Biao
    Liu Xue Zheng
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (02): : 95 - 99
  • [6] Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients
    Makroo, R. N.
    Chowdhry, Mohit
    Kumar, Manoj
    Srivastava, Priyanka
    Tyagi, Richa
    Bhadauria, Preeti
    Kaul, Sumaid
    Sarin, Ramesh
    Das, P. K.
    Dua, Harsh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (04) : 481 - 484
  • [7] HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques
    Ellis, CM
    Dyson, MJ
    Stephenson, TJ
    Maltby, EL
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (07) : 710 - 714
  • [8] Concordance between immunohistochemistry and fluorescence in situ hybridization for assessment of the HER2
    Cho, S. H.
    Lee, M. R.
    Kim, D. C.
    Lee, K. C.
    Lee, J. H.
    Kwon, H. C.
    Lee, H. S.
    Lee, S.
    BREAST, 2011, 20 : S21 - S21
  • [9] High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
    Gown, Allen M.
    Goldstein, Lynn C.
    Barry, Todd S.
    Kussick, Steven J.
    Kandalaft, Patricia L.
    Kim, Patricia M.
    Tse, Christopher C.
    MODERN PATHOLOGY, 2008, 21 (10) : 1271 - 1277
  • [10] HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies
    Robertson, Scott A.
    Cimino-Mathews, Ashley
    Cornish, Toby C.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (01) : 35 - 39